Opaleye Management Inc. - Nov 17, 2021 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Stock symbol
ETON
Transactions as of
Nov 17, 2021
Transactions value $
-$116,713
Form type
4
Date filed
11/19/2021, 03:09 PM
Previous filing
Nov 17, 2021
Next filing
Dec 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETON Common Stock, par value $0.001 per share Sale -$117K -25K -1.04% $4.67 2.38M Nov 17, 2021 By Opaleye, L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Opaleye Management Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $4.6685. The range of sale prices on the transaction date was $4.62 to $4.671 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.